These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 33155341)
1. Neoantigen prediction in human breast cancer using RNA sequencing data. Hashimoto S; Noguchi E; Bando H; Miyadera H; Morii W; Nakamura T; Hara H Cancer Sci; 2021 Jan; 112(1):465-475. PubMed ID: 33155341 [TBL] [Abstract][Full Text] [Related]
2. Prediction and prioritization of neoantigens: integration of RNA sequencing data with whole-exome sequencing. Karasaki T; Nagayama K; Kuwano H; Nitadori JI; Sato M; Anraku M; Hosoi A; Matsushita H; Takazawa M; Ohara O; Nakajima J; Kakimi K Cancer Sci; 2017 Feb; 108(2):170-177. PubMed ID: 27960040 [TBL] [Abstract][Full Text] [Related]
3. Inconsistency and features of single nucleotide variants detected in whole exome sequencing versus transcriptome sequencing: A case study in lung cancer. O'Brien TD; Jia P; Xia J; Saxena U; Jin H; Vuong H; Kim P; Wang Q; Aryee MJ; Mino-Kenudson M; Engelman JA; Le LP; Iafrate AJ; Heist RS; Pao W; Zhao Z Methods; 2015 Jul; 83():118-27. PubMed ID: 25913717 [TBL] [Abstract][Full Text] [Related]
4. Identification of a neoantigen epitope in a melanoma patient with good response to anti-PD-1 antibody therapy. Nonomura C; Otsuka M; Kondou R; Iizuka A; Miyata H; Ashizawa T; Sakura N; Yoshikawa S; Kiyohara Y; Ohshima K; Urakami K; Nagashima T; Ohnami S; Kusuhara M; Mitsuya K; Hayashi N; Nakasu Y; Mochizuki T; Yamaguchi K; Akiyama Y Immunol Lett; 2019 Apr; 208():52-59. PubMed ID: 30880120 [TBL] [Abstract][Full Text] [Related]
5. The impact of tumor profiling approaches and genomic data strategies for cancer precision medicine. Garofalo A; Sholl L; Reardon B; Taylor-Weiner A; Amin-Mansour A; Miao D; Liu D; Oliver N; MacConaill L; Ducar M; Rojas-Rudilla V; Giannakis M; Ghazani A; Gray S; Janne P; Garber J; Joffe S; Lindeman N; Wagle N; Garraway LA; Van Allen EM Genome Med; 2016 Jul; 8(1):79. PubMed ID: 27460824 [TBL] [Abstract][Full Text] [Related]
6. Neoantigen-reactive T cells exhibit effective anti-tumor activity against colorectal cancer. Yu Y; Zhang J; Ni L; Zhu Y; Yu H; Teng Y; Lin L; Xue Z; Xue X; Shen X; Song H; Su X; Sun W; Cai Z Hum Vaccin Immunother; 2022 Dec; 18(1):1-11. PubMed ID: 33689574 [TBL] [Abstract][Full Text] [Related]
8. Identification of WDFY3 Neoantigens as Prognostic Markers in Longterm Survivors of Extrahepatic Cholangiocarcinoma. Wang Y; Jin B; Zhou N; Sun Z; Li J; Chen Q; Wu X; Zhou Y; Shi Y; Lu X; Sang X; Mao Y; Du S; Wang W; Bai C Curr Cancer Drug Targets; 2020; 20(11):875-886. PubMed ID: 32957886 [TBL] [Abstract][Full Text] [Related]
9. Reduced Neoantigen Expression Revealed by Longitudinal Multiomics as a Possible Immune Evasion Mechanism in Glioma. Nejo T; Matsushita H; Karasaki T; Nomura M; Saito K; Tanaka S; Takayanagi S; Hana T; Takahashi S; Kitagawa Y; Koike T; Kobayashi Y; Nagae G; Yamamoto S; Ueda H; Tatsuno K; Narita Y; Nagane M; Ueki K; Nishikawa R; Aburatani H; Mukasa A; Saito N; Kakimi K Cancer Immunol Res; 2019 Jul; 7(7):1148-1161. PubMed ID: 31088845 [TBL] [Abstract][Full Text] [Related]
10. Late-differentiated effector neoantigen-specific CD8+ T cells are enriched in peripheral blood of non-small cell lung carcinoma patients responding to atezolizumab treatment. Fehlings M; Jhunjhunwala S; Kowanetz M; O'Gorman WE; Hegde PS; Sumatoh H; Lee BH; Nardin A; Becht E; Flynn S; Ballinger M; Newell EW; Yadav M J Immunother Cancer; 2019 Sep; 7(1):249. PubMed ID: 31511069 [TBL] [Abstract][Full Text] [Related]
11. Limitations of Detecting Genetic Variants from the RNA Sequencing Data in Tissue and Fine-Needle Aspiration Samples. Kaya C; Dorsaint P; Mercurio S; Campbell AM; Eng KW; Nikiforova MN; Elemento O; Nikiforov YE; Sboner A Thyroid; 2021 Apr; 31(4):589-595. PubMed ID: 32948110 [No Abstract] [Full Text] [Related]
12. Implementation of next generation sequencing into pediatric hematology-oncology practice: moving beyond actionable alterations. Oberg JA; Glade Bender JL; Sulis ML; Pendrick D; Sireci AN; Hsiao SJ; Turk AT; Dela Cruz FS; Hibshoosh H; Remotti H; Zylber RJ; Pang J; Diolaiti D; Koval C; Andrews SJ; Garvin JH; Yamashiro DJ; Chung WK; Emerson SG; Nagy PL; Mansukhani MM; Kung AL Genome Med; 2016 Dec; 8(1):133. PubMed ID: 28007021 [TBL] [Abstract][Full Text] [Related]
13. Mitochondria sequence mapping strategies and practicability of mitochondria variant detection from exome and RNA sequencing data. Zhang P; Samuels DC; Lehmann B; Stricker T; Pietenpol J; Shyr Y; Guo Y Brief Bioinform; 2016 Mar; 17(2):224-32. PubMed ID: 26249222 [TBL] [Abstract][Full Text] [Related]
14. Using RNA-Seq Data for the Detection of a Panel of Clinically Relevant Mutations. Wolff A; Perera-Bel J; Schildhaus HU; Homayounfar K; Schatlo B; Bleckmann A; Beißbarth T Stud Health Technol Inform; 2018; 253():217-221. PubMed ID: 30147077 [TBL] [Abstract][Full Text] [Related]
15. Indication-specific tumor evolution and its impact on neoantigen targeting and biomarkers for individualized cancer immunotherapies. Lo AA; Wallace A; Oreper D; Lounsbury N; Havnar C; Pechuan-Jorge X; Wu TD; Bourgon R; Jones R; Krogh K; Yang GY; Zill OA J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34599029 [TBL] [Abstract][Full Text] [Related]
16. Integrated RNA and DNA sequencing improves mutation detection in low purity tumors. Wilkerson MD; Cabanski CR; Sun W; Hoadley KA; Walter V; Mose LE; Troester MA; Hammerman PS; Parker JS; Perou CM; Hayes DN Nucleic Acids Res; 2014 Jul; 42(13):e107. PubMed ID: 24970867 [TBL] [Abstract][Full Text] [Related]
17. Applications of Next-Generation Sequencing in Neoantigen Prediction and Cancer Vaccine Development. Lancaster EM; Jablons D; Kratz JR Genet Test Mol Biomarkers; 2020 Feb; 24(2):59-66. PubMed ID: 30907630 [TBL] [Abstract][Full Text] [Related]
18. Neoantigen landscape in metastatic nasopharyngeal carcinoma. Lin M; Zhang XL; You R; Yang Q; Zou X; Yu K; Liu YP; Zou RH; Hua YJ; Huang PY; Wang J; Zhao Q; Jiang XB; Tang J; Gu YK; Yu T; He GP; Xie YL; Wang ZQ; Liu T; Chen SY; Zuo ZX; Chen MY Theranostics; 2021; 11(13):6427-6444. PubMed ID: 33995666 [No Abstract] [Full Text] [Related]
19. Modeling clonal structure over narrow time frames via circulating tumor DNA in metastatic breast cancer. Weber ZT; Collier KA; Tallman D; Forman J; Shukla S; Asad S; Rhoades J; Freeman S; Parsons HA; Williams NO; Barroso-Sousa R; Stover EH; Mahdi H; Cibulskis C; Lennon NJ; Ha G; Adalsteinsson VA; Tolaney SM; Stover DG Genome Med; 2021 May; 13(1):89. PubMed ID: 34016182 [TBL] [Abstract][Full Text] [Related]
20. The eSNV-detect: a computational system to identify expressed single nucleotide variants from transcriptome sequencing data. Tang X; Baheti S; Shameer K; Thompson KJ; Wills Q; Niu N; Holcomb IN; Boutet SC; Ramakrishnan R; Kachergus JM; Kocher JP; Weinshilboum RM; Wang L; Thompson EA; Kalari KR Nucleic Acids Res; 2014 Dec; 42(22):e172. PubMed ID: 25352556 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]